Self-Made, Self-Disciplined And Ambitious

[email protected]23 Nov, 2021News

Satish Mehta, MD & CEO, Emcure Pharma is currently having a moment under the sun. Emcure?s subsidiary, Gennova, is developing India?s first indigenously developed mRNA COVID-19 vaccine that is currently undergoing phase II and phase III trials. Mehta is confident about meeting the said target of 60 million doses by the end of 2021, despite the logistics challenges. The company is working towards backward integration of its operations to help de-risk the supply chain.

Recent Profiles

ช่อดอกไม้ไทย

ช่อดอกไม้ไทย

View Profile

Dverto.ai

Dverto.ai

View Profile

Jemima Events Venue

Jemima Events Venue

View Profile

swipe political quiz

Swipe Political Quiz

View Profile

SV388 ⭐️ Khám Phá Nền Tảng Giải Trí

Sv388 ⭐️ Khám Phá Nền Tảng Giải Trí

View Profile

Swosti Grand Bhubaneswar

Swosti Grand Bhubaneswar

View Profile

iuw88com

Iuw88com

View Profile

rifiworifiwo

Rifiworifiwo

View Profile

Cadworks India

Cadworks India

View Profile

98 WIN

98 Win

View Profile